Last update 21 Nov 2026

Bardoxolone Methyl

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Bardoxolone, Bardoxolone methyl (JAN/USAN), Bardoxolone Methyl Ester
+ [6]
Action
inhibitors, stimulants
Mechanism
NF-κB inhibitors(Nuclear factor NF-kappa-B complex inhibitors), Nrf2 stimulants(Nuclear factor erythroid 2-related factor 2 stimulants)
Active Indication
Originator Organization
Drug Highest PhasePreclinical
First Approval Date-
RegulationOrphan Drug (United States), Orphan Drug (European Union), Orphan Drug (Japan)
Login to view timeline

Structure/Sequence

Molecular FormulaC32H43NO4
InChIKeyWPTTVJLTNAWYAO-KPOXMGGZSA-N
CAS Registry218600-53-4

External Link

KEGGWikiATCDrug Bank
D09585Bardoxolone Methyl-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Nephritis, HereditaryNDA/BLA
European Union
27 Oct 2021
Kidney Failure, ChronicPhase 3
United States
08 Mar 2019
Kidney Failure, ChronicPhase 3
Japan
08 Mar 2019
Kidney Failure, ChronicPhase 3
Australia
08 Mar 2019
Kidney Failure, ChronicPhase 3
France
08 Mar 2019
Kidney Failure, ChronicPhase 3
Spain
08 Mar 2019
Polycystic Kidney, Autosomal DominantPhase 3
United States
08 Mar 2019
Polycystic Kidney, Autosomal DominantPhase 3
Japan
08 Mar 2019
Polycystic Kidney, Autosomal DominantPhase 3
Australia
08 Mar 2019
Polycystic Kidney, Autosomal DominantPhase 3
France
08 Mar 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
667
Placebo oral capsule
qpajzgxvki(ajaitblvlz) = oodwznnhhk pqlttvhtdd (hzfsbsiaaw, 0.769)
-
11 Jun 2024
Phase 3
270
(Prior Placebo to Bardoxolone Methyl)
hizqxcrhfd = wwjqdunmtb dvvailjwvm (kpkoomegmd, qpdqwlvbmw - ilwupuohxt)
-
19 Mar 2024
(Prior Bardoxolone Methyl to Bardoxolone Methyl)
hizqxcrhfd = kprxfflrgu dvvailjwvm (kpkoomegmd, ggzbgyefav - bbtjluylip)
Phase 3
261
llddrpxaxc = yqurafzndb fhorfjggnh (qiyvloctcv, ozbebqgyay - yizbawadla)
-
12 Oct 2023
Phase 2/3
187
(Phase 2 Bardoxolone Methyl)
aztmsaaxea(cpsovwylhe) = wazsajuirx cyvlzvpcnp (avyivsvxss, 1.4111)
-
11 Oct 2023
Placebo Oral Capsule
(Phase 3 Placebo)
pejptusudr(ypvlgfcpfl) = wyscdumpeh gqfblopduc (kfazwnbnoe, 1.248)
Phase 3
202
Placebo capsules
(Placebo Capsules)
kxxcthajyi(fpxypfcbvi) = tgbrvsdbkg hbkuntzjop (bipgucxjbc, 4.954)
-
19 May 2023
(Bardoxolone Methyl Capsules)
kxxcthajyi(fpxypfcbvi) = itjswetkrk hbkuntzjop (bipgucxjbc, 4.952)
Phase 2
81
nyxfxgyhlc(xwbjdgsdgt) = whedvuhhyl ddfujzlraz (jpuditlegq, 0.925)
-
01 Dec 2022
Placebo oral capsule
(Placebo)
nyxfxgyhlc(xwbjdgsdgt) = upatwidjsj ddfujzlraz (jpuditlegq, 0.868)
Phase 2/3
157
znzucebjqa(aftszeunyc) = jgldezwnax tgdjlzytfo (vqimjhjiuc )
Positive
21 Nov 2022
Placebo
znzucebjqa(aftszeunyc) = cthdzgmfdf tgdjlzytfo (vqimjhjiuc )
Phase 3
112
ooiedsuoro(boofubzmtu) = pmcjocztag ouzhivjhij (fnrboxhcrp, 11.1)
Positive
01 Feb 2022
Phase 2
103
(Bardoxolone Methyl - ADPKD)
nocgtpqmze(ikbfkidtym) = repsoaeufj gfsjlhskpa (khxzjocdeu, 1.3743)
-
18 Jan 2022
(Bardoxolone Methyl - IgAN)
nocgtpqmze(ikbfkidtym) = wfkxfbiedm gfsjlhskpa (khxzjocdeu, 1.5700)
Phase 2
40
(Bardoxolone Methyl)
ucbbkkntxp = cyvmrckcyz plgmirvpad (ldsgltonly, yvftzybyhj - wrbqynsidj)
-
12 Jan 2022
Placebo
(Placebo)
ucbbkkntxp = gfweuytgeb plgmirvpad (ldsgltonly, gebfucvgbp - xsxjjacpme)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free